Reparixin - CAS# 266359-83-5 10125 S-Ruxolitinib is a less active

S-Ruxolitinib is a less active enantiomer of Ruxolitinib

2R)-1-hydroxy-1-phenylpropan-2-yl]carbamoyl}-1-methoxy-2-methylethyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl](methyl)carbamoyl}-2-methylpropyl]carbamoyl}-2-methylpropyl]-N-methylhexanamide

TC-DAPK 6 is a potent

It was developed as a replacement drug to combat bacteria that had acquired antibiotic resistance to commonly used antibiotics

Formula: C9H12N2O5

Reparixin - CAS# 266359-83-5 10125 S-Ruxolitinib is a less activeReparixin is an inhibitor of CXCR2 function, which attenuates inflammatory responses and promotes recovery of function after traumatic lesion to the spinal cord. In a human breast cancer cell line, both reparixin reduced the number of breast cancer stem cells compared with no treatment. I n mice with primary human breast cancer xenografts, reparixin alone or in combination with docetaxel reduced tumor growth compared with saline control. The